MARA Act gains additional cosponsors but receives no committee markup or hearing before fall recess.

The MARA Act (Medical Alternatives to Reduce Addiction Act) is a proposed US law that would expand access to psychedelic treatments, especially for veterans. More members of Congress are expected to sign on as supporters, but the bill is very unlikely to actually get a formal committee hearing or vote before Congress goes on its fall recess. This is a familiar pattern — bills gain names on a list but stall before any real action.

Double filing builds a cosponsor list, but leadership won't schedule contentious drug legislation pre-election. This pattern has held repeatedly. Anchored to today's MARA double-filing catalyst.